Does Rallies show Form 4 insider transactions for CAH?

Yes. Rallies tracks CAH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CAH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CAH. It does not provide personalized investment advice.

CAH (Cardinal Health, Inc.) Stock Analysis - Insider Trades

Cardinal Health, Inc. (CAH) is a publicly traded Healthcare sector company. As of May 20, 2026, CAH trades at $199.40 with a market cap of $46.79B and a P/E ratio of 0.00. CAH moved -0.48% today. Year to date, CAH is -3.03%; over the trailing twelve months it is +28.73%. Its 52-week range spans $106.98 to $233.60. Analyst consensus is strong buy with an average price target of $246.00. Rallies surfaces CAH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CAH stock inside the company?

Recent CAH insider activity includes Greene Michelle D. sold 100, Greene Michelle D. sold 2.65K, Alt Aaron E sold 2.33K, Hall Patricia Hemingway sold 4.00K, and WEITZMAN DEBORAH sold 21.37K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CAH Key Metrics

Key financial metrics for CAH
Metric	Value
Price	$199.40
Market Cap	$46.79B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.52%
52-Week High	$233.60
52-Week Low	$106.98
Volume	1.49M
Avg Volume	0
Revenue (TTM)	$244.67B
Net Income	$1.68B
Gross Margin	3.69%

Recent CAH Insider Trades

Greene Michelle D. sold 100 (~$22.86K) on Feb 27, 2026.
Greene Michelle D. sold 2.65K (~$604.53K) on Feb 27, 2026.
Alt Aaron E sold 2.33K (~$524.96K) on Feb 18, 2026.
Hall Patricia Hemingway sold 4.00K (~$918.88K) on Feb 6, 2026.
WEITZMAN DEBORAH sold 21.37K (~$3.22M) on Aug 20, 2025.

Latest CAH News

Cardinal Health drops as investors fade Q3 outlook hike, refocus on recall risk — May 6, 2026
Cardinal Health slides despite Q3 EPS beat as traders focus on GAAP and cash flow — Apr 30, 2026
Cardinal Health reports 11% revenue gain, narrows FY26 EPS outlook to $10.70-$10.80 — Apr 30, 2026
Cardinal Health Expands Higher-Growth Services After Health Care Lags 7% — Apr 28, 2026
Cardinal Health slides 3% on profit-taking and pre-earnings repositioning — Apr 22, 2026

CAH Analyst Consensus

12 analysts cover CAH: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $246.00.

Common questions about CAH

Who is trading CAH stock inside the company?: Recent CAH insider activity includes Greene Michelle D. sold 100, Greene Michelle D. sold 2.65K, Alt Aaron E sold 2.33K, Hall Patricia Hemingway sold 4.00K, and WEITZMAN DEBORAH sold 21.37K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CAH?: Yes. Rallies tracks CAH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CAH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CAH. It does not provide personalized investment advice.